Company Comparison
Carmat vs 10x Genomics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Carmat | 10x Genomics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Vélizy-Villacoublay, France | — |
| Founded | 2008 | — |
| Status | Active | Active |
| Last Funding Stage | IPO | — |
| Total Funding | €63M | — |
| Valuation | — | — |
What They Build
Carmat
Carmat develops artificial heart devices designed to replace the function of a failing heart in patients with end-stage heart failure.
10x Genomics
10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.
Key Investors
Sector Overlap
Both Carmat and 10x Genomics operate in Biotech.
Browse all Biotech companies →